Abstract：
UNASSIGNED: Providers who treat patients with psoriasis are unevenly distributed across the United States, with more in urban than rural areas. This retrospective claims analysis characterized disparities in access to care for US patients with psoriasis using data from the STATinMED database.
UNASSIGNED: Patients (≥18 years) had ≥1 claim with a psoriasis diagnosis and ≥1 claim for advanced psoriasis therapy (apremilast or biologics) between January 2015 and December 2019. Access to psoriasis care was determined using the proportion of patients with 0, 1-2, 3-4, or ≥5 providers in their local area.
UNASSIGNED: Overall, 179,688 patients were included in the analysis, 80.0% in urban areas. The access ratio was highest for internal medicine physicians (97.1 per 1000 patients) and lowest for dermatologists (4.4 per 1000 patients) and family practice physicians (3.9 per 1000 patients). In urban areas, 41% of patients had access to ≥5 dermatologists versus 7% in rural areas. Whereas 2% of patients in urban areas sought care outside of their local area, 75% in rural areas did so. Use of advanced therapies was low in all states (<17%).
UNASSIGNED: Access to psoriasis-treating providers varied widely. Regardless of access, utilization of advanced treatments was low, suggesting the need for effective, easy-to-administer therapy.
UNASSIGNED: Patients (≥18 years) had ≥1 claim with a psoriasis diagnosis and ≥1 claim for advanced psoriasis therapy (apremilast or biologics) between January 2015 and December 2019. Access to psoriasis care was determined using the proportion of patients with 0, 1-2, 3-4, or ≥5 providers in their local area.
UNASSIGNED: Overall, 179,688 patients were included in the analysis, 80.0% in urban areas. The access ratio was highest for internal medicine physicians (97.1 per 1000 patients) and lowest for dermatologists (4.4 per 1000 patients) and family practice physicians (3.9 per 1000 patients). In urban areas, 41% of patients had access to ≥5 dermatologists versus 7% in rural areas. Whereas 2% of patients in urban areas sought care outside of their local area, 75% in rural areas did so. Use of advanced therapies was low in all states (<17%).
UNASSIGNED: Access to psoriasis-treating providers varied widely. Regardless of access, utilization of advanced treatments was low, suggesting the need for effective, easy-to-administer therapy.
摘要：
■治疗牛皮癣患者的提供者在美国分布不均，城市多于农村地区。这项回顾性分析使用来自STATinMED数据库的数据，描述了美国银屑病患者在获得治疗方面的差异。
在2015年1月至2019年12月期间，患者（≥18岁）的银屑病诊断索赔≥1例，晚期银屑病治疗（apremilast或生物制剂）索赔≥1例。使用当地0、1-2、3-4或≥5个提供者的患者比例来确定获得牛皮癣治疗的机会。
■总的来说，179,688例患者被纳入分析，城市地区占80.0%。内科医师的访问率最高（每1000名患者97.1名），皮肤科医师（每1000名患者4.4名）和家庭执业医师（每1000名患者3.9名）的访问率最低。在城市地区,41%的患者有≥5名皮肤科医生，而农村地区为7%。而城市地区有2％的患者寻求当地以外的治疗，农村地区有75％的人这样做。所有州使用先进疗法的比例都很低(<17%)。
■获得牛皮癣治疗提供者的途径差异很大。不管访问,先进治疗的利用率低，表明需要有效的，易于管理的治疗。
在2015年1月至2019年12月期间，患者（≥18岁）的银屑病诊断索赔≥1例，晚期银屑病治疗（apremilast或生物制剂）索赔≥1例。使用当地0、1-2、3-4或≥5个提供者的患者比例来确定获得牛皮癣治疗的机会。
■总的来说，179,688例患者被纳入分析，城市地区占80.0%。内科医师的访问率最高（每1000名患者97.1名），皮肤科医师（每1000名患者4.4名）和家庭执业医师（每1000名患者3.9名）的访问率最低。在城市地区,41%的患者有≥5名皮肤科医生，而农村地区为7%。而城市地区有2％的患者寻求当地以外的治疗，农村地区有75％的人这样做。所有州使用先进疗法的比例都很低(<17%)。
■获得牛皮癣治疗提供者的途径差异很大。不管访问,先进治疗的利用率低，表明需要有效的，易于管理的治疗。
